Cryptogenic stroke remains one of the most challenging entities in vascular neurology, accounting for 20–30% of all ischemic strokes even after a standard diagnostic evaluation. With over 200 known causes of ischemic stroke, clinicians must navigate a complex differential that spans cardioembolic sources, large- and small-vessel disease, hypercoagulable states, dissections, vasculitis, and rare or drug-induced etiologies.
This CME activity provides a structured, clinically grounded approach to the evaluation and management of cryptogenic stroke. Learners will review the contemporary classification of ischemic stroke subtypes, examine the role of advanced vascular imaging, and determine when to escalate to transesophageal echocardiography (TEE) to detect left atrial appendage thrombi, complex aortic plaque, and high-risk PFO/atrial septal aneurysm.
A major focus is on embolic stroke of undetermined source (ESUS)—its criteria, limitations, and the lessons learned from key clinical trials (NAVIGATE ESUS, RESPECT ESUS, ATTICUS, ARCADIA), which collectively demonstrated that empiric anticoagulation with DOACs is not beneficial and may be harmful in this population.
The course also highlights the impact of prolonged rhythm monitoring using loop recorders, which can reclassify a substantial proportion of cryptogenic strokes as cardioembolic by uncovering occult atrial fibrillation and directly altering secondary prevention strategies.
Through case-based discussion (including recurrent “Florida woman” cryptogenic strokes), practical mnemonics, and real-world data comparing comprehensive vs community stroke centers, clinicians will gain a pragmatic framework to reduce the size of the “cryptogenic” category, refine workups, and individualize treatment.
The estimated time to complete this activity is 1 hour.
Disclosure Statement
eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content.
All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.
Disclaimer Statement
The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of eMedEd, Inc. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that the FDA does not indicate in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
If you have questions about continuing education credit or certificates related to this course, please contact us via email at contact@emeded.org
Questions about the content, please contact eMedEd, Inc. via email at contact@emeded.org
Copyright © 2024 eMedEd, Inc. All rights reserved. This material may not be reproduced, displayed, modified, or distributed without the express prior written permission of the copyright holder.
Refunds are subject to the following terms:
To request a refund, please email support@emedevents.com with your order details and reason for cancellation.
eMedEvents neither represents any State Medical Board nor claims to provide any online course on behalf of the State Medical Board. Subscribing to any of our CME/CE online courses is entirely at the user's discretion, and they should verify with their State Medical Board for their current re-licensure requirements.